Plasma fibrinogen leaks across the compromised BBB and undergoes coagulation cascade activation and cross-linking by factor XIII. Fibrin(ogen) deposition in the brain parenchyma triggers neuroinflammation via microglial CD18 integrin activation, while D-dimers (fibrin degradation products) enter systemic circulation. Elevated plasma D-dimer thus serves as a functional readout of BBB leakage with coagulation cascade activation—a vascular contribution biomarker distinct from purely neuronal markers like neurofilament light chain. D-dimer testing is widely standardized and clinically available, facilitating rapid validation.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["BBB Breakdown"] -->|"leakage"| B["Plasma fibrinogen leakage"]
B -->|"cascade activation"| C["Coagulation cascade activation"]
C -->|"cross-linking"| D["FXIII cross-linking"]
D -->|"deposition"| E["Fibrin deposition in brain"]
E -->|"integrin binding"| F["Microglial CD18 activation"]
F -->|"pro-inflammatory"| G["Neuroinflammation"]
G -->|"cytotoxic"| H["Neuronal loss and cognitive decline"]
E -->|"degradation"| I["Fibrinolysis and D-dimer elevation"]
Median TPM across 13 brain regions for FGA, FGB, FGG, D-dimer from GTEx v10.
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
7 citations7 with PMIDValidation: 0%4 supporting / 3 opposing
✓For(4)
No supporting evidence
No opposing evidence
(3)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
5
2
MECH 5CLIN 2GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
Fibrinogen leakage into AD brain drives microglial…
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-26 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Mechanistic Hypotheses: BBB Permeability Biomarkers for Neurodegeneration
Hypothesis 1: Soluble PDGFRβ as a Peripheral Pericyte Degeneration Marker
Title: Circulating Soluble PDGFRβ Reflects Pericyte Loss and Precedes Cognitive Decline in Neurodegeneration
Description: Pericyte degeneration is among the earliest events in Alzheimer's disease (AD) and vascular dementia, preceding amyloid deposition and cognitive symptoms. Damaged pericytes release the ectodomain of platelet-derived growth factor receptor β (sPDGFRβ) into the bloodstream, making it a peripheral indicator o
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation: BBB Permeability Biomarkers for Neurodegeneration
I will systematically evaluate each hypothesis for mechanistic plausibility, specificity, technical feasibility, and potential confounds. Where applicable, I will identify issues that span multiple hypotheses.
Hypothesis 1: Soluble PDGFRβ (Original: 0.82)
Specific Weaknesses
Non-CNS sources of sPDGFRβ: PDGFRβ is expressed on pericytes, vascular smooth muscle cells (VSMCs), cardiac fibroblasts, hepatic stellate cells, and renal mesangial cells. Systemic inflammatory conditions (atherosclerosis, pul
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Biomarker Utility: HIGH — sPDGFRβ functions as a pharmacodynamic/response biomarker rather than a direct therapeutic target. The underlying PDGFRβ signaling axis, however, represents a legitimate therapeutic target.
Therapeutic Approaches: | Strategy | Agent Class | De
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
{"ranked_hypotheses": [{"title": "Circulating Soluble PDGFRβ Reflects Pericyte Loss and Precedes Cognitive Decline in Neurodegeneration", "description": "Soluble PDGFRβ (sPDGFRβ) is released into the bloodstream upon pericyte damage, serving as a peripheral indicator of blood-brain barrier (BBB) pericyte coverage loss. Elevated plasma sPDGFRβ correlates with BBB leakage and cognitive decline trajectories. The mechanism involves ADAM10/ADAM17-mediated ectodomain shedding of PDGFRβ from damaged pericytes. This hypothesis has the strongest evidence base with human validation in Alzheimer's dise
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
If plasma D-dimer elevation specifically reflects fibrinogen leakage through compromised BBB rather than systemic fibrinolysis, then D-dimer levels will correlate with BBB permeability markers (Qalb, sPDGFRβ) and with fibrinogen deposits in brain tissue (postmortem), but not with systemic coagulation parameters (PT, aPTT, platelet count).
pendingconf: 0.50
Expected outcome: In paired plasma/CSF samples (n≥100) with postmortem tissue available, plasma D-dimer correlates with Qalb (r>0.5), sPDGFRβ (r>0.4), and brain parenchymal fibrinogen deposits (IHC score, r>0.4), but shows no correlation with PT, aPTT, or platelet count, distinguishing BBB leakage from systemic coagulation.
Falsified by: Plasma D-dimer correlates with systemic coagulation parameters (PT, aPTT) equally as with BBB markers; brain fibrinogen deposits do not correlate with plasma D-dimer, indicating systemic fibrinolysis dominates plasma D-dimer rather than brain-derived fibrin degradation.
Method: Cross-sectional biomarker study with postmortem validation: plasma D-dimer, Qalb, sPDGFRβ, coagulation panel; brain tissue fibrinogen IHC scoring (n≥40 postmortem cases); correlation and path analysis for fibrinogen leakage vs systemic coagulation contributions.